Physician profile
Nancy Allen
NPI 1992062574
$21,167.72
in general payments reported to CMS, 2019-2025
16 companies · $780 in 2025
The $780 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.56 · 2022: $19K · 2023: $495 · 2024: $1,012 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,287.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18,681.95 | 2022 | |
| Abbvie INC. | $757.44 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $418.49 | 2024-2025 | Ingrezza |
| Alkermes, INC. | $217.25 | 2023-2025 | Lybalvi, Aristada |
| Teva Pharmaceuticals USA, INC. | $169.08 | 2023-2025 | Uzedy, Austedo Xr |
| Novo Nordisk INC | $162.34 | 2024-2025 | Wegovy |
| Supernus Pharmaceuticals, INC. | $161.60 | 2022-2024 | Qelbree, Qelbree |
| Axsome Therapeutics, INC. | $151.29 | 2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $150.47 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $89.71 | 2022-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Masimo Corporation | $74.80 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.14 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $37.29 | 2024-2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $32.31 | 2023 | Spravato, Invega Sustenna |
| Astrazeneca Pharmaceuticals Lp | $11.56 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $10.00 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.